Table 1 (abstract ABS015) Overall cohort comparison between Groups 1/2 and Group 3
From: Abstracts from the British Society of Echocardiography annual meeting 2023
|  | Group 1/2 (N = 7504) | Group 3 (N = 6277) | P-value |
|---|---|---|---|
Participant demographics | |||
Male (%) | 4236/7504 (56.4) | 3620/6277 (57.0) | 0.15 |
Median age (years) (IQR) | 66 (57–73) | 65 (56–73) |  |
Median BMI (kg/m2) (IQR) | 28.2 (24.98–31.83) | 28.27 (25.10–31.84) |  |
Current smoker (%) | 884/7206 (12.3) | 755/6065 (12.4) | 0.75 |
Ex-smoker (%) | 2755/7206 (38.2) | 2062/6065 (34.0) | < 0.001 |
Non-smoker (%) | 3567/7206 (49.5) | 3248/6065 (53.6) | < 0.001 |
Hypertension (%) | 3434/7099 (48.4) | 3312/6261 (52.9) | < 0.001 |
Hypercholesterolaemia (%) | 2836/7099 (39.9) | 2970/6261 (47.4) | < 0.001 |
Diabetes mellitus (%) | 1412/7014 (19.9) | 1422/6261 (22.7) | < 0.001 |
Peripheral vascular disease (%) | 206/7099 (2.9) | 97/6258 (1.6) | < 0.001 |
Family history of premature CAD (%) | 480/7099 (6.8) | 2112/6261 (33.7) | < 0.001 |
Previous MI (%) | 1273/7088 (18.0) | 1108/6258 (17.7) | 0.70 |
Previous PCI (%) | 2311/7102 (32.5) | 1312/6258 (21.0) | < 0.001 |
Precious CABG (%) | 542/7115 (7.6) | 439/6258 (7.0) | 0.18 |
Resting RWMA (%) | 1097/7452 (14.7) | 718/4984 (14.4) | 0.63 |
Stress echocardiogram details | |||
Exercise (%) | 2289/7504 (30.5) | 2292/6131 (37.4) | < 0.001 |
Pacemaker (%) | 26/7504 (0.3) | 31/6131 (0.5) | 0.15 |
Dobutamine (%) | 5232/7504 (69.7) | 3808/6131 (62.1) | < 0.001 |
Atropine use in DSE (%) | 2585/5232 (49.4) | 1686/3808 (44.3) | < 0.001 |
Contrast used | 5376/7480 (71.9) | 5168/6180 (83.6) | < 0.001 |
SonoVue (%) | 4957/5376 (92.2) | 4158/5168 (80.5) | < 0.001 |
Luminity (%) | 401/5376 (7.5) | 1006/5168 (19.5) | < 0.001 |
Other (e.g. Optison) (%) | 18/5376 (0.3) | 4/5168 (0.1) | < 0.001 |
No contrast (%) | 2104/7480 (28.1) | 1012/6180 (16.4) | < 0.001 |